These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30961676)

  • 1. Effect of the rigidification of propranolol, a mixed
    Franchini S; Sorbi C; Linciano P; Brasili L; Tait A
    Pharmazie; 2019 Mar; 74(3):131-135. PubMed ID: 30961676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
    Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
    Baker JG; Adams LA; Salchow K; Mistry SN; Middleton RJ; Hill SJ; Kellam B
    J Med Chem; 2011 Oct; 54(19):6874-87. PubMed ID: 21870877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
    Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
    J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of propranolol analogues as serotonergic agents.
    Pierson ME; Lyon RA; Titeler M; Schulman SB; Kowalski P; Glennon RA
    J Med Chem; 1989 Apr; 32(4):859-63. PubMed ID: 2539480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring-hydroxylated propranolol: synthesis and beta-receptor antagonist and vasodilating activities of the seven isomers.
    Oatis JE; Russell MP; Knapp DR; Walle T
    J Med Chem; 1981 Mar; 24(3):309-14. PubMed ID: 6115057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluation of the antifibrillatory effect of fluorinated derivatives of carazolol and celiprolol: comparison with propranolol.
    Almotrefi AA; Dzimiri N; Aboul-Enein HY; Premkumar LS
    Gen Pharmacol; 1993 May; 24(3):721-5. PubMed ID: 8103496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine Seeking During Initial Abstinence Is Driven by Noradrenergic and Serotonergic Signaling in Hippocampus in a Sex-Dependent Manner.
    Kohtz AS; Aston-Jones G
    Neuropsychopharmacology; 2017 Jan; 42(2):408-418. PubMed ID: 27515792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
    Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
    J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on relationships between chemical structure and beta-blocking potency of bopindolol and its two metabolites.
    Nagatomo T; Ishiguro M; Ohnuki T; Hattori K; Hosohata Y; Takatsu N; Katayama H; Watanabe K
    Life Sci; 1998; 62(17-18):1597-600. PubMed ID: 9585142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
    Zhang D; Ma Q; Shen S; Hu H
    Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. -Adrenergic blocking agents. 12. Heterocyclic compounds related to propranolol.
    Crowther AF; Howe R; McLoughlin BJ; Mallion KB; Rao BS; Smith LH; Turner RW
    J Med Chem; 1972 Mar; 15(3):260-6. PubMed ID: 4400583
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
    Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
    Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of propranolol-cyclic analogues.
    Castagnino E; Corsano S; Strappaghetti G; Brasili L; Gallucci P
    Farmaco Sci; 1983 Sep; 38(9):679-85. PubMed ID: 6139297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 4'-hydroxypropranolol sulfate, a major non-beta-blocking propranolol metabolite in man.
    Oatis JE; Walle T; Daniell HB; Gaffney TE; Knapp DR
    J Med Chem; 1985 Jun; 28(6):822-4. PubMed ID: 2861287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A; Brixius K; Bölck B; Schwinger RH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT
    Del Bello F; Cilia A; Carrieri A; Fasano DC; Ghelardini C; Di Cesare Mannelli L; Micheli L; Santini C; Diamanti E; Giannella M; Giorgioni G; Mammoli V; Paoletti CD; Petrelli R; Piergentili A; Quaglia W; Pigini M
    ChemMedChem; 2016 Oct; 11(20):2287-2298. PubMed ID: 27690321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.